Our mission to identify the outstanding women working in corporate investment continues with this updated list focused on the US East Coast.

This series of Women in CVC and the conversations with female investors and portfolio development managers, spearheading industry units, has shown us that the traditionally male-dominated industry is diversifying. 

As told by the people on the inside, the corporate VC industry is attracting ever diverse talent, not just in terms of gender, but experience, expertise, interests and background, working on innovative projects from various sectors.   

For instance, Gabby Munoz, global head of M&A and venture investments at Fitch Group sees an “increasing prevalence of women in the financial services field, certainly at an executive level, [which] is evolving.”  

Regarding opening avenues to women in the industry, she believes exposure is key. “I think that women both on the investor and the founder side are more than capable. It’s a matter of getting more people into the field early on, so they can develop their career in this space,” she says. 

Over the past three years, GCV has been featuring women working in CVC, region by region. As part of the series, we will be updating the regions of the US Midwest and American South, Mediterranean Europe, DACH region (Germany, Austria, Switzerland), Asia, the Middle East and Latin America with new faces. We continue to look for women in the sector to add to our lists. If there is anyone we have left off, please let us know.

Alison Perez

  • Senior investment manager and portfolio manager
  • Lockheed Martin Ventures
  • Based in Washington, D.C.

“I was originally on the engineering and research side of Lockheed Martin. After a point, I began working with a number of venture portfolio companies. So, when a role opened up on the venture team, I came over and it’s been wonderful. I’ve been here for almost five years now,” says Alison Perez, senior investment and portfolio manager at Lockheed Martin Ventures (LMV). 

LMV is the corporate VC arm of US aerospace, arms, defence, information security and technology producer Lockheed Martin. Founded in 2007, the unit makes strategic investments in early-stage companies through its $200m evergreen fund. 

Perez handles LMV’s space investment portfolio. “I do a lot of our space, AI and advanced materials deals, along with a number of human potential deals, which includes training, digital transformation – anything that would help a human counterpart.” 

Although the defence sector is heavily male-dominated, Perez counts herself as fortunate to have had a lot of support from mentors and fellow colleagues.   

“I’ve had folks be my champion and be really receptive to me and my ideas. And I know that is an experience that doesn’t happen everywhere. So, I feel very grateful because I’ve seen other women in this space struggle,” says Perez. 

“People say that representation really matters, and it’s funny, I didn’t really recognise it until a little bit later in my career. I started seeing women come up through the corporate structure and realised, oh there’s a person whose path I can follow and make it my own. But without that representation, it’s hard to have any sort of framework for how to build your own career.” 

Perez hopes diversity in the CVC industry will continue to improve. “Bias exists because people don’t have context, exposure or experience with different kinds of people. So, maybe being that gregarious and inclusive person yourself can help them understand how it’s really the way to make the ecosystem better as a whole. And hopefully, the younger women that I see coming up through engineering and are willing to work in the defence space will find it to be a changing environment and culture.”

Shalei Holway

  • Head of portfolio development
  • RTX Ventures 
  • Based in New York

Shalei Holway didn’t originally intend to work in corporate investing but feels “remarkably fortunate to be in this position”. 

She spent nearly three years working with the Department of Defence to develop a programme to incentivise VC firms in technologies critical to national security. It was only once that initiative was up and running that she began considering her next step, realising that she wanted to pivot to venture investing. 

“I was speaking with several investors in the defence space when a mentor told me about an opportunity on the RTX Ventures team. After talking with Dan Ateya, who leads our team, I was drawn to the way corporate venture capital can drive both revenue growth and technological advancement for portfolio companies,” says Holway.  

“I’m an operator at heart—that’s where I’ve spent most of my career—and I knew I wanted to join a firm that offers more than just capital.” 

RTX Ventures is the CVC subsidiary of US aerospace and defence technology group RTX. Launched in 2022, the unit invests in early-stage companies in cybersecurity, propulsion, AI and precision sensing. 

Holway focuses on developing the unit’s strategy for two core areas – “forming impactful partnerships between our portfolio companies and RTX businesses and telling those stories of value creation internally within RTX, and to the broader investment community. I’m also looking ahead and building our strategy to scale the high touch support we provide to founders as our portfolio grows.” 

Holway counts herself as fortunate to have had strong mentors, both in RTX and outside. “Some of my closest mentors are women who lead financial VC firms and regularly co-invest with corporate VCs like ours. Their perspective is incredibly helpful in shaping how I articulate the strategic value that RTX Ventures brings to our portfolio companies and to other investors.” 

She believes having a range of perspectives in CVC is essential.  

“Research shows that differences in experience, background, and ways of thinking leads to better decision-making and more resilient investment strategies. That holds especially true in corporate venture investing, where we’re constantly balancing strategic and financial priorities,” says Holway. 

“At RTX Ventures, we’re fortunate that Dan cultivates an environment where everyone on the team is encouraged to contribute to investment discussions. The more CVC leaders can create a culture where all voices are heard and constructive debate is welcomed, the better the outcomes will be—for both the fund and our portfolio companies.”

Gabby Munoz

  • Global head of M&A and venture investments
  • Fitch Group 
  • Based in New York

Gabby Munoz has a diverse range of professional experience, having started her career in investment banking and subsequently joining the global growth equity firm General Atlantic. She then clocked time at an e-commerce startup “where I got the other side of the coin, not as an investor, but as an operator, building a business, which was really interesting,” she says.  

Munoz’s entry into venture came in 2012 when she joined diversified information services company Hearst, initially on the corporate development team. Munoz spent about three years in the role, before moving into more of a strategy role, helping various business units think about strategy and growth, both organic and inorganic. Later she joined Hearst Ventures, Hearst’s corporate venture arm.  

“I got a lot of exposure to corporate venture, looking at early-stage companies across insurance, fintech, e-commerce and other businesses. And then I got the opportunity to go lead M&A for our newly formed e-commerce division.”  

This led her to her current role as managing director, global head of M&A and venture investments at Hearst’s financial services subsidiary Fitch Group, focusing on identifying emerging technologies and businesses in credit intelligence and other segments of the financial information services ecosystem.  

One area of CVC she identifies as both complex and rewarding is the strategic alignment to the parent company.  

When making an investment in CVC, “there’s a very important balance between the financial side and the strategic side, and how you consider those two things when you’re looking at an investment opportunity. I think that that’s probably the biggest challenge. You’re not just looking for the best companies. You’re also looking for the companies that fit into your thesis and into your corporate strategy,” Munoz says.  

While used to working in sectors where women have been underrepresented, this is an area she can see changing, with exposure to the CVC industry playing a part.  

“I think that there is an increasing prevalence of women in the financial services field, certainly at an executive level and it’s evolving,” she says.  

“I think that women both on the investor and the founder side are more than capable. It’s a matter of getting more people into the field early on, so they can develop their career in this space.”

Sara Olson

  • Senior director, crop science venture investments
  • Leaps by Bayer
  • Based in Boston, Massachusetts

Sara Olson joined the investment team at Leaps by Bayer in September 2022 to focus on investments at the intersection between agriculture, food and consumer health. 

She believes the role of agriculture is fundamentally changing – from novel sources of crop protection to the way products are made, sold, applied and measured. As senior director of crop science venture investments at Leaps, she hopes to bring out technologies at the leading edge of that change, building the future of agriculture by investing in the things that seem impossible today but will become inevitable with the right support. 

Founded in 2015, Leaps by Bayer is the corporate VC arm of German pharmaceuticals company Bayer. The unit was set up to target big societal challenges, from reducing the environmental impact of agriculture to treating cancer.  

The CVC invests in early-stage startups and has a portfolio of more than 65 companies. Total capital invested exceeds $2bn. 

Olson started her career at advisory company Lux Research, where she helped launch the firm’s coverage of agtech. She then moved into corporate venturing, first at FMC Ventures and then at Leaps.  

Olson was listed as one of GCV’s Rising Stars for 2025 for her work on crop traits and epigenetics, food tech and on-farm automation.

Rachel Zabronsky

  • Principal
  • PayPal Ventures
  • Based in New York

Rachel Zabronsky’s route into corporate venturing came through the marketing function. She worked in communications and marketing at media analytics firm Nielsen and for biometric identification startup CLEAR before joining PayPal in a business-to-business marketing role.   

This gave her a grounding in go-to-market and both B2B and consumer products, which prepared her to take an active role in the PayPal Ventures team, the corporate VC arm of the payments tech company. 

Later, Zabronsky was introduced to the ventures team when she joined PayPal’s Technology Leadership Programme, which chooses 10 people from across the company for a series of six-month rotations on different teams. She was successful in the programme and went on to join the investment team as a principal in 2022. 

Zabronsky enjoys working with founders to help them grow their businesses. “That also stems from my experience as an operator, working out how to create connectivity and diving into the weeds with them,” Zabronsky previously told GCV. 

A hot trend she predicts to continue is increased fintech innovation, spurred by the ongoing advances in AI. Consumer loyalty tech is another area where she sees investment potential as she is looking at the impact of AI on how people shop, such as the use of AI ‘agents’.  

Beyond her investment leads, Zabronsky supports underrepresented people as part of a PayPal team that deploys $100m to 19 minority-led venture capital funds. She continues her work on improving and championing diversity in the VC ecosystem.

Lauren Wisniewski

  • Senior manager
  • New Incubation Ventures
  • Based in New York

Lauren Wisniewski had a long journey that led her to corporate venturing and helped prepare her for her current role at The Estée Lauder Companies’ investment arm, New Incubation Ventures (NIV).   

NIV partners with founders and entrepreneurs to create, fund and support beauty brands and business models to participate in shaping the future of beauty. The CVC also builds a pipeline of diversified brands for the Estée Lauder Companies portfolio. 

Wisniewski started off in equity sales and trading at Canadian multinational bank Scotiabank, which taught her about what investors look for in an investment.  

She then worked on securing financing for public companies, which helped her develop an interest in driving corporate innovation. This was followed by stints at WW (formerly  Weight Watchers) and a VC firm in New York.  

After she joined NIV in 2021 as a senior manager, Wisniewski’s goal has not just been to fund founders and entrepreneurs but to also support them. She and her team members are always on the lookout for the best emerging beauty brands, hoping to discover new business models in beauty, defining what the next generation of the industry is going to look like. 

Wisniewski has played a key role in expanding NIV’s portfolio with six new investments, including beauty brands KIKI World, Vyrao and Melt Season. 

Tassbieh Hassan

  • Manager of portfolio development
  • Salesforce Ventures
  • Based in New York

After starting her career as an electrical engineer in IBM’s semiconductor division — where she earned several patents — Tassbieh Hassan found herself in pursuit of a more client-centric role, in the intersection of technology and people. 
 
Her background in improv comedy has been a useful asset amid the pace and unpredictability of working with clients. “That really helped develop thinking-on-my-feet skills, which I’ve carried all throughout my career.” 

She first moved internally to IBM’s Watson Group consulting team, where she gained early exposure to real-world AI applications. Then in 2020, Hassan joined Salesforce’s New York City office as a senior solutions engineer where she collaborated with startups and Fortune 500 companies to design and deliver digital transformation initiatives for her clients. 

While changing career paths could be daunting, “whether it is 5,10,15 or 30 years down the line, paying attention to your inner voice and taking a calculated risk, regardless of your previous path, is worth it,” she previously told GCV.  

From there, Hassan joined Salesforce Ventures as a senior analyst, a role that let her bring together her technical expertise and client instincts to drive innovation.  

Now a manager of portfolio development at Salesforce Ventures, Hassan is part of a team that has deployed over $6bn in capital in more than 500 startups, partnering with software companies such as Anthropic, Writer and ElevenLabs. She collaborates with startup CEOs and enterprise CIOs and CTOs — building trusted relationships, then launching initiatives to connect emerging technologies with real enterprise needs. With a foundation in engineering and a strong sense for partnership, she helps bridge early-stage ambition with enterprise-scale impact. 

As the CVC role comes with its positives and challenges, she believes it’s important to not be spread too thin in the role. “An appeal of working in CVC, especially for those who are naturally curious, is that you get to see so much and speak to so many stakeholders, but this needs to be balanced against an ability to prioritise what is most important day to day.” 

Hanqing Li

  • Investment director
  • MSD Global Health Innovation Fund
  • Based in New York

Hanqing Li serves as an investment director in MSD Global Health Innovation fund, managed by US healthcare company MSD, but having started her career in academia, her initial career goal was far different — becoming a professor. 

The drive to make a real-world impact is what steered her towards the CVC industry. 

“I thought corporate venture would be the perfect vehicle for that. In venture you get exposed to the latest innovations in science and technology. Working at a corporate VC in a large format like MSD means you have the potential to generate some impact with the startups,” Li previously told GCV.

Li joined the fund in 2021 and has carved out a niche in AI-equipped drug discovery, where she helped to lead rounds for BigHat Biosciences and Variational AI.  

Li also appreciates the diversity of her team at the Global Health Innovation Fund, where she can bring experience in research and intellectual property law, and work closely with colleagues who expose her to new areas of expertise.  

Emphasising the strengths of diversity of talent, she said: “We are a very eclectic group, everyone has different backgrounds and that has been amazing for me, because it means I get to learn across the pharma and healthcare value chain, all the way from supply chains, manufacturing and R&D to go-to-market strategies.”

Eve Burton

  • Chairwoman
  • HearstLab 
  • Based in New York

Eve Burton is passionate about investing in women-led early-stage companies as part of HearstLab, the corporate venture capital accelerator of US media and business services firm Hearst. 

The CVC arm is supported by a community of 200 female executives from across Hearst’s global ecosystem who volunteer to scout for companies and assist the startups with advice post-investment.   

As part of the larger organisation, Burton serves as executive vice president and chief legal officer of Hearst, with the firm’s key areas including cable entertainment, interactive and emerging digital media, local broadcast television, magazines, newspapers and real estate. 

There is also an emphasis on business information companies that create and deliver content for the global finance, healthcare and transportation industries.  

By background, Burton is a US first amendment lawyer, focused on protecting freedom of the press, with her career leading her to work for the New York Daily News, as well as a chief counsel at CNN. This experience helped her progress to an executive vice president and chief legal officer of Hearst, as well as being a member of Hearst’s board of directors.  

HearstLab was founded in 2016, focusing primarily on B2B enterprise technology, data analytics, media, healthcare, finance and transportation. Burton secured the firm’s first $250,000 investment about a decade ago. Now the CVC arm has deployed more than $85m and spans a $2.5bn portfolio. 

Luba Safran

  • Venture capital lead
  • Mondelēz 
  • Based in New York

Luba Safran leads venture capital for Mondelēz International’s SnackFutures Ventures, which she joined in January 2024.  

SnackFutures was founded in 2018 to support snack brands and technologies that can strengthen Mondelēz’s core businesses and accelerate innovation. 

Before Mondelēz, Safran worked at AB InBev from 2013 as a global innovation manager. She held a variety of strategic growth roles at the company where she gained experience launching new products and brands in multiple global markets. 

Then she was appointed director at AB InBev’s CVC, ZX Ventures, shortly after its launch in 2015. ZX Ventures closed in 2024.

Prior to AB InBev, Safran worked as a client services manager at advertising firm STC Associates and as a marketing coordinator at law practise Dewey & LeBoeuf.

Annie Weissbach

  • Senior associate, strategic investment
  • Echo Health Ventures 
  • Based in Boston, Massachusetts

Annie Weissbach has been with Echo Health Ventures since June 2022 and supports the team through all aspects of the investment process – from deal sourcing and evaluation to transaction management and execution. 

Weissbach’s career and general interest in public health stems from the way she grew up. Her formative years in Tokyo, London and Florida gave her the chance to understand how different cultures have different health systems and the ways in which people respond to them.  

It was this interest that led her to explore public health opportunities in local government and policy during her Master of Public Health studies, followed by a stint at Mammosphere, a digital health startup focused on women’s health, as well as a business degree, and a job in healthcare investment banking to her corporate venturing role at Echo Health Ventures. 

Founded in 2016, Echo Health Ventures invests on behalf of four Blue Cross Blue Shield health insurers, in a bid to drive healthcare transformation through focused investing. Some of the team’s recent investments include ThymeCare, a value-based cancer care enabler, and Vori Health, a musculoskeletal disease care company. 

Weissbach’s responsibilities include providing financial and market analysis for both the investment team at Echo and for the portfolio companies. She also serves as a board observer for Wildflower Health, Heartbeat Health, TytoCare and Upfront Healthcare. 

Weissbach was listed as one of GCV’s Rising Stars for 2025.

Ankita Singh

  • Investment director
  • Bosch Ventures
  • Based in Cambridge, Massachusetts

Ankita Singh joined Bosch Ventures in March 2023, and was drawn to the company because of its excellent mix of technical and financial people. 

“My background, coming from consulting, also brings out the strategy side of things – being able to see a company’s potential in terms of market sizing, in terms of the strategic aspects,” Singh previously told GCV. 

Bosch Ventures is the corporate VC arm of German multinational engineering and technology company Robert Bosch. The unit was founded in 2007 and has offices worldwide, including in the US, Europe, China and Israel. It invests in between six and 10 companies a year and its portfolio has more than 60 active investments.  

One of GCV’s Rising Stars for 2025, Singh says her role at Bosch Ventures incorporates everything she has done before, with the breadth of technologies being explored making the most of her experience in deep-tech diligence.  

Jenna Kurath

  • Vice president of startup partnerships and head of Comcast NBCU SportsTech
  • Comcast 
  • Based in Philadelphia, Pennsylvania

Jenna Kurath joined US mass media and telecommunications multinational Comcast in 2013 and has held various positions, the most recent as vice president of startup partnerships and head of Comcast NBCU SportsTech since December 2019. 

Before joining Comcast, she held various business development, sales strategy and communications roles at companies ranging from the startup and pre-IPO stage to Fortune 500 companies, such as Symantec and Concentric Networks. 

Launched in 2020, Comcast NBCUniversal SportsTech is a global innovation programme focused on finding, funding and developing sports technologies. Ten high potential startups are selected and funded each year and given strategic guidance from decision makers at the most prominent sports brands. 

Kurath is responsible for architecting and leading the partnership strategy, partner relations and resource management of the SportsTech innovation programme. Her team focuses on startups innovating in fan/player engagement, media and entertainment, athlete/player performance, venue and event innovation, team/coach success, business of sports, fantasy sports and betting and esports.

34 women in venture we highlighted previously

In 2023, we shone a light on 34 standout women in venturing on the US East Coast. Check them out below.

Dina Samra
  • Director of business development
  • New York Life Ventures
  • Based in New York

Sometimes it can seem that everyone in the VC world has the same background in finance and consulting. But Dina Samra didn’t let those conventions hold her back.

“The venturing world can be hard to break into. I thought that I would need an MBA to break into the VC world and I thought that there was a lot of prejudice around types of degrees that someone may have, but I was wrong,” says Dina Samra.

Samra says that rigorous networking and showing creative capabilities beyond a qualification is what has allowed her to thrive in the sector.

Samra spent four years at MassChallenge, the zero equity startup developer., where she was director of partnerships and strategic partner manager, before joining New York Life Ventures.

She has been director of business development at unit, the corporate venture arm of New York Life Insurance Company, for nearly two years.

Founded in 2012, New York Life Ventures invests in sectors from healthcare to enterprise software. It has 22 companies in its portfolio, including Brella Insurance, a US-based health insurance advisor.

Samra focuses on areas such as proptech and fintech, and aims to help startups in these fields start collaborations with large enterprises.

Samra believes that CVCs should avoid seeking out the “usual suspects” and must actively employ underrepresented groups.

“I still come across CVCs that contain ten men and one woman, so CVCs need to push themselves to get a pipeline of resumes during the hiring process to make sure more diverse backgrounds are entering our market,” she says.

Samra also believes that everyone plays a role in promoting gender diversity in the sector, including herself. “I want to open up my network and be helpful to anyone that is looking to break into the corporate venturing space, and I ask all women to do that,” she says.

She continues: “We have already made huge strides but continuing to foster an open door policy and having tough conversations will increase the number of women entering these roles.”

Jaya Balasubramaniam
  • Head of incubation, strategy and operations
  • Store No.8
  • Based in New Jersey

Jaya Balasubramaniam is the head of incubation, strategy and operations at Store No.8, the investment arm of the US-based retail corporation Walmart.

Established in 2017, Store No. 8 builds startups in transformational areas for retail, with the intent that they will eventually become a part of Walmart at scale. The incubator currently has portfolio companies in areas like mixed reality, health & wellness, the metaverse, decentralized commerce and more.

Balasubramaniam has worked at Store No. 8 for three years. Prior to that, she spent more than a decade as a founding member of Deloitte’s Venture Accelerator, building a portfolio of B2B product businesses.

She has a background in Tech Investment Banking at Merrill Lynch, and strategy and corporate development at JP Morgan. She has served as an advisor at the United Nations Development Program, the UN Capital Fund, and currently coaches startup founders at the Lang Fund at Columbia Business School.

Alisa Band
  • Senior investment manager
  • Henkel Tech Ventures
  • Based in Connecticut

Alisa Band is the senior investment manager at Henkel Tech Ventures, the corporate venture capital of German chemicals and consumer developer Henkel.

Launched in 2016, Henkel Tech Ventures typically invests in Industry 4.0, material sciences and dispensing equipment. Henkel Tech Ventures has 14 companies in its portfolio.

Henkel Tech Ventures has also seen several of its startups exit such as Thermexit, a thermal management solutions provider which was acquired by Henkel Adhesives Technologies.

Band has held her position at Henkel for three years. Born in the US, Band later moved to Israel where she completed her army service and degrees in chemistry and material sciences at Hebrew University and The Weizmann Institute. In 2017, she moved back to the US, where she started working as the global head of tech and startup scouting at ICL Group.

Beforehand, she worked as a business development manager for Ramot, the technology transfer arm of the Univeristy of Tel Aviv and founded the healthcare and medical fertility platform Fertil-IT.

Andrea Chico
  • Business development manager
  • Ferguson Ventures
  • Based in Fort Lauderdale

From the start of her career Andrea Chico, business development manager at Ferguson Ventures, has been passionate about uplifting women.

“I’m heavily involved in the women’s business resource group at Ferguson where I have had the opportunity to mentor with leaders and manage our portfolio. Having the opportunity to mentor someone in the CVC ecosystem helped me understand what it took to join corporate ventures,” says Chico.

Chico joined Ferguson, a construction industry distributor, nine years ago starting in the company’s sales department. She joined the corporation’s venture unit in 2022.

Chico says that establishing her career in corporate venturing was not smooth sailing.

“When I first became interested in the corporate venturing sector, the issue wasn’t how do I get into venture capital it was when is the right time. I knew I wanted to focus on strategy and I needed to strengthen this skill so I found a mentor who helped me,” she says.

Founded in 2018, Ferguson Ventures invests in early-stage companies focusing on startups that drive innovation in construction, property maintenance, and environmental. The firm has invested in 17 companies in its portfolio including Greyter, a Canada-based water solutions provider that raised $10m in a series B round this early this year.

As an advocator for diversity in the workplace, Chico believes that corporate venturing would benefit from a greater gender balance. “We have an opportunity to encourage and introduce diversity of thought and once we achieve that through greater conversation we will generate stronger results.”

She continues: “A rising tide lifts all boats, so continuing to advocate for women in our industry and being their biggest cheerleader is how we will encourage more women to enter into corporate venturing.”

Barbara Dalton
  • Senior managing partner
  • Pfizer Ventures
  • Based in New York

Barbara Dalton is the senior managing partner of Pfizer’s corporate venture arm, Pfizer Ventures. The New York-based corporate venturing veteran is also the vice president of worldwide business development for Pfizer.

Established in 2004, Pfizer Ventures is a $600m unit that invests in medical companies in the US with a focus on rare diseases, oncology and vaccines. The firm has 54 startups in its portfolio and has overseen 94 company exits including Zura Bio, a US-based novel medicine developer that exited via reverse merger in 2023.

Other notable investments include drug discovery platform Jhana Therapeutics which raised $107m in 2022, and dark matter decoder Nucleome Therapeutics which raised $47.5m in a series A round in 2022.

Dalton has been running Pzifer Ventures for 16 years. She has personally managed more than 30 fund investments and 80 company investments since.

Dalton has acquired extensive experience in the pharmaceutical industry having worked for ten years as president of SROne, GSK’s corporate venture fund. She later joined the $260m venture firm EuclidSR Partners as a partner in 2000 before joining Pfizer.

Dalton was listed on the GCV Powerlist in 2023 and received the Global Corporate Venturing Lifetime Achievement award in 2019.

Kai Daniels
  • Supervising principal
  • GM Ventures
  • Based in Michigan

Kai Daniels is supervising principal at GM Ventures, the corporate venture arm of General Motors, the US-based automotive manufacturing giant.

Founded in 2010, GM Ventures invests in the transport sector focusing on automotive cleantech and automotive technology companies. The unit has around 31 companies in its portfolio and has invested in over 110 startups, including UK-based dynamic holography innovator Envisics which recently raised $50m in a series C round.

GM Ventures has also overseen 30 startup exits including Novasentis, a US-based developer of sensor technology to develop wearable consumer electronic products, which was acquired by Kemet in 2019.

Based in Michigan, Daniels began working at General Motors in 2013 as a business analyst and project manager intern. She then progressed to GM Ventures in 2016 starting as an associate before progressing to her current position early this year.

She was also listed as one of GCV’s Rising Stars for her engagement in strategic partnership negotiations along with portfolio implementation. Prior to her time at General Motors, Daniels was a legislative intern at the Florida House of Representatives.

Lisa Dufresne
  • Associate
  • GC Ventures
  • Based in Boston

Boston-based Lisa Dufresne is an associate at GC Ventures, the corporate venture unit of the Thailand-based chemicals corporation, PTT Global Chemicals.

GC Ventures was founded in 2018 and invests in digital platforms, energy storage and life sciences companies. The corporate arm has 10 startups in its portfolio including, Arevo, a US-based carbon fibre 3D printing company.

Other startups that GC Ventures has invested in include NirvaMed, a US-based developer of heart muscle damage technology for heart attack patients, and Inkbit, the US-based additive manufacturing platform.

PTT Global Chemicals is a $6.5bn petrochemical company with eight business areas including a Polymers Business Unit and an Aromatics division.

Dufresne has been a part of the GC Ventures team for four years and previously served as a senior consultant for Foresight Science and Technology for 16 years. She has a Master’s in Civil and Environmental Engineering at Tufts University.

Morgan Flately
  • Head of new business ventures and global chief marketing officer
  • McDonald’s Ventures
  • Based in Illinois

Morgan Flately is the head of new business ventures and global chief marketing officer at McDonald’s Ventures, the corporate venture arm of US-based multinational fast food chain McDonald’s.

McDonald’s Ventures is actively seeking new investment opportunities. So far, the firm has invested in one startup called Redbox Entertainment, a provider of content entertainment access. McDonald’s later acquired Redbox Entertainment until Chicken Soup for Soul Entertainment acquired the company in 2022.

A food industry marketing expert, Flately has been a part of the McDonald’s family for over six years. She started as the corporation’s chief of marketing and digital customer experience officer before progressing to her current position in 2021.

She previously spent 12 years at US-based snack and beverage corporation PepsiCo where she held various positions including vice president of brand marketing of Gatorade, a sports themed beverage, and senior vice president and chief marketing officer of global nutrition.

Jenna Foger
  • Senior vice president
  • Alexandria Venture Investments
  • Based in New York

Jenna Foger is senior vice president at Alexandria Venture Investments, the corporate venture arm of California-headquartered real estate company Alexandria Real Estate Equities.

Established in 1996, Alexandria Venture Investments invests in seed to growth stage companies in the healthcare, agrifood and climate innovation sectors. The unit has 158 companies in its portfolio and has invested in 358 startups, including Georgiamune, a US-based developed of dual functioning monoclonal antibodies that completed a $75m series A round this month.

Foger has been working in New York for over 15 years. She began her career as a senior consultant at Easton Associates before its acquisition by Navigant Consulting and later became an associate for Windham Venture Partners in 2013.

Foger joined Alexandria Venture Investments in 2014 and plays an active role in identifying new syndicate partners and liaising with the local life science venture community through the firm’s Seed Capital Platform. Foger was also listed in GCV’s Powerlist in 2022 and 2023.

Darcy Frisch
  • Managing director and vice president
  • Hearst Ventures
  • Based in New York

Darcy Frisch is managing director and vice president at Hearst Ventures, the subsidiary of the US-based multinational mass media conglomerate Hearst Corporation.

Launched in 1995, Hearst Ventures invests in media and entertainment industries and has 61 companies in its portfolio such as UK-based eCommerce fulfillment technology provider Huboo.

Frisch is based in New York and has held her position at Hearst Ventures for over 23 years. Her role includes being an observer on several startup boards, including the on-demand transit app, Via, and the mobile advertising platform Nexage.

Before Hearst, she was at KPMG and worked as a legislative assistant for Senator David Boren.

Allison Goldberg
  • Senior vice president and managing partner
  • Comcast Ventures
  • Based in New York

Allison Goldberg is senior vice president & managing partner at New York-headquartered Comcast Ventures, the corporate unit of telecommunications giant Comcast.

Founded in 1999, Comcast Ventures invests in seed to later-stage startups operating in digital health, fintech, and workforce sectors. The firm has around 129 companies in its portfolio and has invested in close to 500 startups including US-based housing and interior design website, Houzz.

Comcast Ventures has also seen close to 196 startup exits such as SundaySky, the Israeli-headquartered video creation platform that was acquired by Clearhaven Partners for over $100m+ in 2022.

Golberg has been in the venture capital business for over 20 years. She started as a venture capital associate in 2000 for the investment firm Groupe Arnault. Golberg then spent 17 years at the investment arm of Time Warner, and two years at the Touchdown Ventures.

Angie Grimm
  • Head of unit and vice president of corporate development
  • IBM Ventures
  • Based in New York

Angie Grimm is the head of IBM Ventures, the corporate venture capital of the US-based technology corporation, IBM. She also serves as the vice president of corporate development for IBM.

Founded in 2001, IBM Ventures invests in IT-based startups focusing on quantum, data and security developments. The firm has 11 companies in its portfolio and has invested in over 41 startups.

The team has overseen 24 exits including EnterpriseDB, a US-based software services company that was acquired private equity firm Great Hill Partners in 2019.

Grimm is a company veteran, starting her career at IBM in 2002 as a team lead for corporate development and market insights. She then progressed to director of investor relations in 2016 before joining IBM Ventures as the director and head of business development for IBM Research and Cloud & Cognitive Software.

Marie-Helene Kennedy-Payen
  • Senior director of operations and community
  • New York Life Ventures
  • Based in New York

Based in New York, Marie-Helene Kennedy-Payen is the senior director of operations and community at New York Life Ventures, the corporate venture capital of the insurance company New York Life.

Founded in 2012, New York Life Ventures invests in innovative technology companies from healthcare to enterprise software. The corporate unit has 22 companies in its portfolio, including DataRobot, a US-based artificial intelligence lifecycle platform that has raised $1bn in funding.

Payen joined New York Life Ventures in 2021 where she is responsible for creating and executing the communications and community strategy for the business, as well as managing the daily operational needs.

Throughout her career, Payen developed a passion for advancing women in financial services and has taken on multiple leadership roles, including acting as a Board Member for the Financial Women’s Association, a New York-headquartered female professional networking organisation dedicated to promoting the advancement of all women across the financial sector.

Paulina Hill
  • Partner
  • Sanofi Ventures
  • Based in Massachusetts

Paulina Hill is the partner at Sanofi Ventures, the corporate venture arm of France-based pharmaceutical and healthcare corporation Sanofi.

Founded in 2001, Sanofi Ventures invests in biotechnology and digital health companies focusing on rare diseases and gene therapy. The firm has 37 companies in its portfolio and has made close to 100 investments including novel therapeutics developer Escient Pharmaceuticals which has raised $237.5m.

Sanofi Ventures has also overseen 31 startup exits such as US-based neurodegenerative diseases treatment designer Yumanity Therapeutics which was acquired by Kineta via a reverse merger in 2022.

As a healthcare expert, Hill has been a partner at Sanofi Ventures for nearly two years. She previously was part of the healthcare investment team at Polaris Partners for six years and acted as a board observer for several companies such as Arrakis Therapeutics and IFM Therapeutics.

Meg Krench
  • Director of investments
  • Sanofi Ventures
  • Based in Massachusetts

Meg Krench is the director of investments at Sanofi’s corporate subsidiary, Sanofi Ventures.

Founded in 2001, Sanofi Ventures invests in early stage companies focusing on a range of healthcare innovations including rare diseases and oncology. Startups in Sanofi Ventures’ portfolio include the medication management flow platform Medisafe, which raised $30m in 2021.

Krench has been a part of Sanofi Ventures since 2021 focusing on transformative medicines and patient solutions. Her position has allowed her to become a board observer for several startups including ALS treatment developer QurAlis.

As a scientist by training, Krench acquired a Doctorate in Neuroscience at MIT. She also spent three years at RA Capital Management as a senior associate and served two years as a consulting intern at CBT Advisors.

Coppelia Marincovic
  • Partner
  • Solvay Ventures
  • Based in New York

Coppelia Marincovic is a partner at Solvay Ventures, the corporate unit of the Belgium-based chemicals company, Solvay.

Founded in 2005, Solvay Ventures invests in varying sectors from commercial products to sustainable resources. They have invested in 17 companies and have 11 in their portfolio including Invizius, a spinout of the University of Edinburgh that has developed complement therapies to treat kidney diseases.

Based in New York, Marincovic has been a part of Solvay Ventures for seven years starting as the firm’s investment manager for North America. She then was promoted to her current position in April 2022 where is has personally overseen three exits, such as Multimechanics which was acquired by Siemens.

Voted as one of GCV’s Emerging Leaders in 2023, Marincovic was previously an engagement manager at McKinsey focusing on pharmaceutical and chemicals companies. She also worked as a senior consultant at Next47-backed sustainability organisation Thinkstep.

Jennifer McKellar
  • Senior director
  • CME Ventures
  • Based in New York

Jennifer McKellar is the senior director of CME Ventures, the corporate venture capital financial exchange corporation CME Group.

Founded in 2014, CME Ventures invests in disruptive early stage technology companies. The firm has 13 companies in its portfolio and has invested in 54 startups such as Switzerland-based information services company Kemiex and US-based electronic and digital liquidity platform Blockfills.

McKellar has been CME Ventures’ senior director for nine years. Her position has allowed her to be the board observer for several startups including Symphony and Acadia Soft.

Before joining CME Group, McKellar spent four years as a senior vice president at Citigroup and the vice president of Barclays Capital, the corporate investment banking division of Barclays.

Marian Nakada
  • Vice president of venture investments
  • JJDC
  • Based in Cambridge, Massachusetts

Marian Nakada is the vice president of venture investments at Johnson & Johnson Innovation – JJDC, the corporate venture firm of US-based pharmaceutical conglomerate, Johnson & Johnson.

Founded in 1973, Johnson & Johnson Innovation – JJDC invests in startups typically in the seed to series A stage. They seek out companies focusing on pharmaceuticals, medical devices and consumer healthcare sectors.

The firm has 114 startups in its portfolio and has invested in close to 500 companies. JJDC startups have achieved more than 180 startup exits, one of the most notable if which was Syndesi Therapeutics which was acquired by AbbVie for $1bn in 2022.

Nakada has been at JJDC for nearly 11 years. Her focus is on venture investments on the East Coast and she works closely with the Boston Innovation Center.

Before JJDC she was at Janssen, Johnson & Johnson’s daughter company as a strategy, operations and external innovation lead. Nakada also spent eight years at another Johnson & Johnson subsidiary, Centocor as a senior director of business development and senior director in oncology research.

Shannon Neumann
  • Director
  • SnackFutures Innovation
  • Based in New Jersey

Shannon Neumann is the director at SnackFutures Innovation, the corporate innovation and venture hub of US-based confectionery and food conglomerate Mondelēz International.

Launched in 2018, SnackFutures Innovation invests in emerging startups and businesses that are creating new snacking opportunities across the globe. The firm provides a $20,000 grant and 12-week mentorship programmes to startups.

SnackFutures Innovation has 20 startups in its portfolio including US-based producer of plant-based protein bars Mezcla and Every Body Eat, a manufacturer of snacks intended for people with or without dietary restrictions.

Neumann is a veteran in the food and beverage industry starting off as a brand coordinator for seasonal confections at Nabisco. She later was hired by Kraft Food Groups and spent five years in the corporation holding positions such as senior associate brand manager and brand manager of biscuits.

In 2009, she moved to Cadbury, a Mondelēz International-owned company, where she acted as the brand and innovation manager. After three years, Neumann progressed to Mondelēz International where she continued to hold managerial positions until she joined the corporation’s venture unit in 2019.

Neumann started off as SnackFutures Innovation’s associate director and then was promoted to her current position in 2022.

Marie-Christine Razaire
  • Principal
  • Northwestern Mutual Future Ventures
  • Based in New York

Marie-Christine Razaire, who is based in New York, is the principal at Northwestern Mutual Future Ventures, the corporate arm of financial services company, Northwestern Mutual.

Founded in 2017, Northwestern Mutual Future Ventures invests in sectors ranging from digital health to finance. The unit has 31 startups in its portfolio and has invested in 53 other companies, including homecare services provider The Helper Bees which secured a series B funding round in 2022.

Razaire joined Northwestern Mutual Future Ventures in 2019 as an associate before progressing to her current position last year. Prior to this, she spent a year as a scouting manager at US-based insurance company, State Farm, and spent three years at another insurance company, Validus Group, where she held positions such as innovation team manager and fintech underwriter.

Madison Rezaei
  • Head
  • Verizon Ventures
  • Based in New York

Madison Rezaei is the head of the New Jersey-based corporate unit Verizon Ventures, a subsidiary of the telecommunications conglomerate, Verizon Communications. She also serves as the company’s vice president of new business strategy.

Founded in 2000, Verizon Ventures finances early stage companies innovating the telecommunications, media and consumer sectors. The firm has 58 companies in its portfolio.

Rezaei joined Verizon two years ago and was listed on the GCV Powerlist in 2023.

Before Verizon, she spent eight years as a director at Altman Solon, a Boston headquartered telecommunications and media consulting firm. During her time there, she led the Women in Technology group to promote the entry of women into the male-dominated tech sector.

Ginger Rothrock
  • Senior director
  • HG Ventures
  • Based in Indianapolis

Ginger Rothrock is senior director at HG Ventures, the corporate venture arm of the US-based energy and construction conglomerate, The Heritage Group.

Founded in 2018, HG Ventures invests in a range of early-stage startups working on everything from advanced materials to environmental solutions. The firm has some 32 companies in its portfolio, including Vartega, the US-based advanced materials recycler, and US-based solar panel recycling services provider, SolarCycle.

The Heritage Group is a $227m corporation and fourth generation family owned business. The business hires more than 5,000 individuals and has 170 growing locations across the globe.

Based in Indianapolis, Rothrock began her career at HG Ventures nearly five years ago. Prior to this, she spent seven years at the US-based nonprofit organisation RTI International where she held various positions including senior director of commercialisation and intrapreneurship and vice president of technology and commercialisation.

Dina Routhier
  • President
  • Stanley Ventures
  • Based in Boston

Dina Routhier is the president of Stanley Ventures, the corporate subsidiary of Stanley Black & Decker, the US-based industrial tool manufacturer.

Founded in 2016, Stanley Ventures is a $100m venture fund that invests in IT and industrial sectors such as SaaS, construction technology and advanced materials startups. The corporate arm has 36 startups in its portfolio and has invested in over 55 companies.

Stanley Ventures has overseen nine exits, with the most notable being VizExplorer, the US-based business intelligence casino gaming industry platform that was acquired by Dry Line Partners earlier this year.

Routhier has been working in the Boston region for over 20 years. Before joining Stanley Ventures in 2017 she was director of corporate development of corporate venture capital for five years at Autodesk, the US-based software corporation where she executed over $135m in acquisitions.

Michelle Russey McCarthy
  • Managing director
  • Verizon Ventures
  • Based in New Jersey

Michelle Russey McCarthy is the managing director of Verizon Ventures the corporate unit of the telecommunications conglomerate, Verizon Communication.

Founded in 2000, Verizon Ventures finances early stage companies innovating the telecommunications, media and consumer sectors. The firm has 58 companies in its portfolio and has made 179 investments in startups.

Verizon Ventures has overseen 61 startup exits such as US-based machine learning technology developer AdTheorent which exited via IPO and listed on NASDAQ in 2021, and Israel-based imaging software solutions provider Beamr Imaging which exited via IPO on NASDAQ this year.

Based in New Jersey, McCarthy is a Verizon veteran having worked for the corporation for 28 years. She joined the company in 1995 as the manager of corporate strategy and held other positions such as head of LIHTC Investments and portfolio management and director of corporate strategy, development, and planning.

She has a Masters in Finance from Georgetown University McDonough School of Business and a Bachelors degree in International Studies and German from American University.

Madelyn Rutter
  • Senior director of collaboration
  • TechNexus Venture Collaborative
  • Based in Chicago

Madelyn Rutter is the senior director of collaboration at TechNexus Venture Collaborative, a Chicago-headquartered corporate venture capital firm.

TechNexus Venture Collaborative was founded in 2007 and invests in early stage companies in the audio consumer electronics, health and mobility sectors. The firm has 114 companies in its portfolio and has invested in 229 companies such as video relationship management platform Gather Voices.

Rutter has worked for TechNexus Venture Collaborative for four years, starting as the unit’s senior manager of collaboration before being promoted to her current position in April this year. She also spent a decade at Kantar, a marketing data and analytics company where she held positions including director of early stage qualitative innovation and senior director of innovation. Rutter was named as one of the Global Corporate Venturing Rising Stars in 2023.

Kathryn Scheckel
  • Managing director
  • Hines Global Venture Lab
  • Based in New York

Kathryn Scheckel is the managing director at Hines Global Ventures, the New York-based corporate venture arm of the real estate developer Hines Interests.

Founded earlier this year, Hines Global Ventures invests in emerging real estate technologies, businesses and technologies that directly solve the greatest challenges facing our industry and our environment.

Hines Global Ventures’ enterprise includes a venture studio where they incubate and accelerate new ideas, an investment platform designed to invest in promising startups, and a partnerships arm to catalyse built-world technology solutions. The firm’s three thematic areas of focus include the evolving use of physical space, revolutionary built-world technologies, and next-generation ESG solutions.

Scheckel started working at Hines in 2019 working across various roles in strategy and innovation. Before joining Hines Scheckel was a management consultant at McKinsey.
She has a Bachelor of Science and Bachelor of Arts from Arizona State University.

Fei Shen
  • Managing director
  • Boehringer Ingelheim Venture Fund USA
  • Based in Massachusetts

Fei Shen, who is based in Massachusetts, is the managing director at Boehringer Ingelheim Venture Fund USA, the corporate subsidiary of US-based pharmaceutical company Boehringer Ingelheim Corporation.

Established in 2010, Boehringer Ingelheim Venture Fund USA is a $326m fund that invests in therapeutic and digital healthcare startups focusing on immuno-oncology, gene therapy and the microbiome. The fund has 41 companies in its portfolio.

The fund has also overseen 17 startup exits such as Hookipa Pharma which exited via IPO for $75m on NASDAQ.

Shen joined Boehringer Ingelheim in 2015 as a senior principal scientist in immunology and respiratory research before joining the corporation’s venture fund in 2020 as the investment director.

Prior to this, Shen spent eight years at Theravance Biopharma, a US-based biopharmaceutical company, where she held positions such as scientist in the pharmacology department. She was also listed as one of GCV’s 50 Emerging Leaders in 2023 where her ambitions to create new medications and improve patients’ lives garnered her recognition.

Ting-Ting Liu
  • Investor
  • Prosus Ventures
  • Based in New York

Ting-Ting Liu is an investor at Prosus Ventures, the corporate venturing arm of Netherlands-based internet group Prosus.

Launched in 2015, Prosus Ventures invests in technology companies focusing on e-commerce, blockchain and software-as-a-service across Asia, Europe and the Americas. The firm has 84 companies in its portfolio including online pharmacy PharmEasy which has raised $1.2bn in funding.

Prosus Ventures has overseen 18 startups exit with its most notable being US-based intelligence platform SimilarWeb which filed for IPO on NASDAQ in 2021.

Liu has been an investor at Prosus Ventures since 2018. She has been noted as a vital member of the investment team providing unique insights into technology and potential investments in the industry. She was also listed as GCV’s Rising Star in 2022.

Previously, Liu spent three years as a management consultant at McKinsey & Company and also spent several months working as a performance engineer for Reebok.

Allison Toman
  • Director of venture capital
  • Medtronic Ventures
  • Based in Massachusetts

Allison Toman is the director of venture capital at US-based medical technology and services provider Medtronic.

Medtronic is a $96.5bn corporation that operates in more than 150 countries and develops and manufactures healthcare technologies and therapies. The company has invested in companies focusing on medical devices and pharmaceutical sectors.

Medtronic’s notable investments include developer of balloon dilation technology Entellus Medical which was acquired by Entellus Medical for $662m in 2017, and SetPoint Medical, a manufacturer of implantable neuromodulation devices for chronic inflammatory diseases which raised $80m in 2023.

Tomann began her stint at Medtronic in 2018 as the senior associate of corporate development. She has since held other positions such as director of corporate development and senior manager of corporate development. In 2021, she progressed to her current position.

Prior to this, Tomann spent seven years as a manager at HealthScape Advisors, a US-based management consulting firm for healthcare industry clients. She also attended the University of Chicago and acquired a master’s in health care management at The Wharton School.

Tina Tosukhowong
  • Investment director
  • TDK Ventures
  • Based in Greater Boston

Tina Tosukhowong joined TDK Ventures in 2021 after spending almost five years at GC International, a subsidiary of PTT Global Chemical, a Thailand-based chemicals manufacturer. At GC International she helped set up its corporate venturing arm, GC Ventures America, and recruited investment team members. One of the portfolio companies she invested in, ESS, a long-duration energy storage manufacturer, listed on the New York Stock Exchange.

Tosukhowong’s passion and focus is the decarbonisation sector. TDK Ventures, the venture arm of the Japanese electronics manufacturer, has invested in technologies such as hydrogen electrolysers and lithium extraction.

She recently led TDK Ventures’ investment into Type One Energy, a startup developing nuclear fusion reactors using Stellarator technology.

Tosukhowong was named one of GCV’s Emerging Leaders for 2022.

Laura Veroneau
  • Managing partner
  • Optum Ventures
  • Based in Boston

Laura Veroneau is the managing partner and founding team member at Optum Ventures, the corporate venture capital of US-based healthcare services provider Optum.

The venture unit was launched in 2017 and typically invests in digital health and other healthcare related sectors. The firm has around 50 companies in its portfolio and has invested in close to 100 startups, including UAE-based digital healthcare platform for chronic condition management, Alma Health which raised $10m in a series A round this year.

Optum Ventures has also overseen over 11 startup exits, with its most notable being the Hayward headquartered pharmacy telehealth solutions connector Trupill, which was acquired by UK digital pharmacy group Phlo Technologies after reaching unicorn status in 2021 with a $1.6bn valuation.

Veroneau has been a part of the Optum Ventures team for over six years, starting off as the firm’s principal. Listed on GCV’s 2023 Powerlist, she personally led notable investments such as US-based social service network provider Unite Us, which raised $195.6m.

Before Optum Ventures, Veroneau spent a year at UnitedHealth Group working in their corporate strategy team. She also worked for two years as manager of product development at Dovetail Health, a US-based tailored medications solutions platform. and sits on the board of overseers for Brighman and Women’s Hospital.

Hope Walls
  • Associate
  • Nationwide Ventures
  • Based in Ohio

Hope Walls is an associate at Nationwide Ventures, the corporate venture arm of a US-based insurance and financial services corporation Nationwide Mutual Insurance Company.

Founded in 2016, Nationwide Ventures invests in early to later stage startups focusing on various sectors such as insurance, mobility and cybersecurity. The venture firm has 29 companies in its portfolio such as digital insurance agency Matic, which raised $24m in a series B round in 2020.

Nationwide Ventures has also overseen two startups exit including Bloom, a US-based financial management and investment advisory platform that was acquired by Morgan Stanley in 2020.

Walls has been working for Nationwide for six years starting as the company’s finance leadership rotation program intern. From there, she held various positions such as finance leadership rotation program associate and analyst for Nationwide Ventures.

She began working as the firm’s associate in 2020 before taking a brief hiatus in 2022 from Nationwide and began working as an FP&A associate for Parsley Health. She then rejoined Nationwide Ventures in March of this year.

She also worked for other corporations include Honda of America as a financial accounting intern and has acquired a Bachelors in Finance at Ohio Wesleyan University.

Deborah Zajac
  • Director
  • Touchdown Ventures
  • Based in New York

Deborah Zajac is a director at Touchdown Ventures, the US-based corporate venture capital unit and venture capital-as-a-service (VCaaS) firm.

Launched in 2014, Touchdown Ventures partners with corporations to invest in early and growth-stage companies focusing on sectors ranging from IT to media. The firm has 83 startups in its portfolio including the US-based text summarisation software developer Agolo.

Notable investments include Gooten, a print-on-demand company headquartered in New York. Gooten closed its $11m series A round last month with participation from global manufacturer INX International and venture firm KEC Ventures.

Based in New York, Zajac has been Touchdown’s director for over seven years. She previously was the senior director for three years at GE Ventures, the corporate unit of US-based conglomerate, General Electric.

Alba Zurriaga Carda
  • Director of general investments
  • Sanofi Ventures
  • Based in New York

Alba Zurriaga Carda is the director of digital investments at Sanofi Ventures, the corporate venture arm of France-based pharmaceutical and healthcare corporation Sanofi.

Founded in 2001, Sanofi Ventures invests in biotherapeutic and digital health entrepreneurs focusing on helping patients and transforming healthcare systems. The firm has 37 companies in its portfolio and has made close to 100 investments including maternal vaccine developer Minerva which has raised $158.1m.

Sanofi is a $135.2bn conglomerate that manufactures and markets prescription drugs globally. It is also considered one of the world’s largest producers of vaccines.

Carda has held her position at Sanofi Ventures for over a year. She focuses on leading investments and strategies in digital health and data science innovations in rare diseases, oncology and potential cures.

Before joining Sanofi, Carda spent two years at venture capital fund 500 Global holding positions such as head of global innovation strategy and manager of corporate innovation and venturing. She also spent three years at Deloitte as a senior innovation consultant for the global open innovation team.